galantamine and Body Weight

galantamine has been researched along with Body Weight in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (7.69)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (30.77)	29.6817
2010's	7 (53.85)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Brines, M; Chavan, SS; George, SJ; Hepler, TD; Hyde, D; Pavlov, VA; Rishi, A; Thompson, DA; Tracey, KJ; Tsaava, T	1
Devi, U; Gautam, S; Kaithwas, G; Kumar, A; Pandey, R; Raghav, N; Rawat, JK; Roy, S; Sammi, SR; Singh, M; Yadav, RK	1
Droogsma, E; Huinink, EJ; Schuur, T; van Asselt, DZ; van Steijn, JH	1
Huang, RH; Li, JT; Si, TM; Su, YA; Wang, XD	1
Ali, MA; Attia, AS; El-Abhar, HS; Kamel, MA	1
Isik, AT; Soysal, P	1
Chavan, S; Dancho, M; Harris, YT; Hudson, LK; Ochani, M; Olofsson, PS; Pavlov, VA; Rosas-Ballina, M; Roth, J; Satapathy, SK; Tracey, KJ; Valdes-Ferrer, SI	1
Bunzeck, N; Dolan, RJ; Duzel, E; Guitart-Masip, M	1
Doetkotte, R; Kiianmaa, K; Opitz, K; Winterhoff, H	1
Bimonte-Nelson, HA; French, KL; Granholm, AC	1
Peskind, ER; Raskind, MA; Wessel, T; Yuan, W	1
Ding, C; Kershaw, P; Lilienfeld, S; Morris, JC; Solomon, PR; Tariot, PN	1
Cozanitis, DA	1

Trials

2 trial(s) available for galantamine and Body Weight

Article	Year
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology, 2000, Jun-27, Volume: 54, Issue:12 Topics: Aged; Alzheimer Disease; Apolipoproteins E; Body Weight; Cholinesterase Inhibitors; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Galantamine; Humans; Male; Neuropsychological Tests; Treatment Outcome	2000
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology, 2000, Jun-27, Volume: 54, Issue:12 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Behavioral Symptoms; Body Weight; Cholinesterase Inhibitors; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Neuropsychological Tests; Severity of Illness Index; Treatment Outcome	2000

Article

Year

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

Neurology, 2000, Jun-27, Volume: 54, Issue:12

Topics: Aged; Alzheimer Disease; Apolipoproteins E; Body Weight; Cholinesterase Inhibitors; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Galantamine; Humans; Male; Neuropsychological Tests; Treatment Outcome

2000

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

Neurology, 2000, Jun-27, Volume: 54, Issue:12

Topics: Activities of Daily Living; Aged; Alzheimer Disease; Behavioral Symptoms; Body Weight; Cholinesterase Inhibitors; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Neuropsychological Tests; Severity of Illness Index; Treatment Outcome

2000

Other Studies

11 other study(ies) available for galantamine and Body Weight

Article	Year
Galantamine ameliorates experimental pancreatitis. Molecular medicine (Cambridge, Mass.), 2023, Oct-31, Volume: 29, Issue:1 Topics: Acetylcholinesterase; Acute Disease; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Body Weight; Ceruletide; Cytokines; Galantamine; Humans; Mice; Pancreatitis	2023
Galantamine attenuates N,N-dimethyl hydrazine induced neoplastic colon damage by inhibiting acetylcholinesterase and bimodal regulation of nicotinic cholinergic neurotransmission. European journal of pharmacology, 2018, Jan-05, Volume: 818 Topics: Acetylcholinesterase; Animals; Biomarkers; Body Weight; Cholinesterase Inhibitors; Colonic Neoplasms; Dimethylhydrazines; Galantamine; Hydrogen-Ion Concentration; Oxidative Stress; Rats, Wistar; Receptors, Nicotinic; Synaptic Transmission	2018
Effect of long-term treatment with galantamine on weight of patients with Alzheimer's dementia. The journal of nutrition, health & aging, 2013, Volume: 17, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Body Weight; Caregivers; Cholinesterase Inhibitors; Female; Galantamine; Humans; Longitudinal Studies; Male; Netherlands; Retrospective Studies; Sex Factors; Weight Loss	2013
Impaired working memory by repeated neonatal MK-801 treatment is ameliorated by galantamine in adult rats. European journal of pharmacology, 2014, Feb-15, Volume: 725 Topics: Animals; Animals, Newborn; Behavior, Animal; Body Weight; Cholinesterase Inhibitors; Dizocilpine Maleate; Female; Galantamine; Locomotion; Male; Memory, Short-Term; Pregnancy; Rats; Rats, Sprague-Dawley; Spatial Behavior	2014
Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug. PloS one, 2015, Volume: 10, Issue:8 Topics: Adipokines; Animals; Apoptosis; Biomarkers; Blood Glucose; Body Weight; Brain; Caspase 3; Cholinesterase Inhibitors; Cytochromes c; Diabetes Mellitus, Experimental; Disease Models, Animal; Galantamine; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Inflammation Mediators; Insulin; Lipid Metabolism; Lipids; Liver; Muscle, Skeletal; Rats; Signal Transduction; Wnt Signaling Pathway	2015
Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study. The journal of nutrition, health & aging, 2016, Volume: 20, Issue:4 Topics: Acetylcholinesterase; Activities of Daily Living; Aged; Body Mass Index; Body Weight; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Eating; Female; Follow-Up Studies; Galantamine; Geriatric Assessment; Humans; Indans; Male; Nutrition Assessment; Nutritional Status; Piperidines; Polypharmacy; Retrospective Studies; Rivastigmine	2016
Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Molecular medicine (Cambridge, Mass.), 2011, Volume: 17, Issue:7-8 Topics: Adipokines; Adiposity; Animals; Blood Glucose; Body Weight; Cholesterol; Cholinesterase Inhibitors; Cytokines; Diet, High-Fat; Eating; Fasting; Fatty Liver; Galantamine; Inflammation; Insulin; Male; Mice; Mice, Inbred C57BL; Obesity; Resistin; Time Factors; Treatment Outcome; Weight Gain	2011
Pharmacological dissociation of novelty responses in the human brain. Cerebral cortex (New York, N.Y. : 1991), 2014, Volume: 24, Issue:5 Topics: Attention; Body Weight; Brain; Brain Mapping; Cholinesterase Inhibitors; Dopamine Agents; Exploratory Behavior; Female; Galantamine; Healthy Volunteers; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neural Pathways; Photic Stimulation; Reaction Time; Recognition, Psychology; Repression, Psychology; Young Adult	2014
Reduction of voluntary ethanol consumption in alcohol-preferring Alko alcohol (AA) rats by desoxypeganine and galanthamine. European journal of pharmacology, 2005, Oct-17, Volume: 522, Issue:1-3 Topics: Alcohol Drinking; Analysis of Variance; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Ethanol; Female; Galantamine; Quinazolines; Rats; Time Factors	2005
Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats. Cell transplantation, 2007, Volume: 16, Issue:3 Topics: Aging; Animals; Behavior, Animal; Body Weight; Cholinesterase Inhibitors; Cues; Female; Galantamine; Humans; Male; Maze Learning; Memory; Nerve Growth Factors; Perception; Rats; Rats, Inbred F344; Spatial Behavior	2007
Experiences with galanthamine hydrobromide as curare antagonist. Der Anaesthesist, 1971, Volume: 20, Issue:6 Topics: Adult; Age Factors; Aged; Androstanes; Body Weight; Drug Hypersensitivity; Female; Galantamine; Gallamine Triethiodide; Heart Rate; Humans; Injections, Intradermal; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Piperidines; Salivation; Steroids; Tubocurarine; Vertigo	1971